A routine follow-up examination one year after breast augmentation led to the detection of a suspicious breast lesion in a 39-year-old woman, who was subsequently diagnosed with invasive breast cancer.
The patient, identified as Kim, visited Ho Cao Vu, a surgeon with a master's degree in medicine, on Sept. 8, 2026.
During the examination, Vu detected a firm, relatively immobile mass in the upper outer quadrant of her right breast. He referred her for ultrasound, which identified a 13-by-12-mm lesion classified as BI-RADS 4, indicating a suspicious abnormality requiring further investigation. A separate cyst was classified as BI-RADS 3, or probably benign.
The axillary lymph nodes appeared benign, and no obvious implant rupture was detected.
A specialized ultrasound on Sept. 14 classified the lesion as BI-RADS 4C, indicating a high suspicion of malignancy. An ultrasound-guided core needle biopsy collected six tissue samples the same day.
Histopathology results issued on Sept. 15 confirmed Grade 2 invasive breast carcinoma, with findings involving adipose tissue and an intraductal component.
![]() |
|
The surgical team performs breast-conserving tumor excision. Photo courtesy of Dr. Ho Cao Vu |
A chest CT scan on Sept. 17 showed a 9-mm nodule in the right breast but no suspicious enlargement of the axillary lymph nodes or abnormalities in the lungs, pleura or mediastinum. However, these findings alone could not rule out cancer spread elsewhere.
After reviewing the results, Vu recommended breast-conserving surgery to remove the tumor while preserving as much healthy breast tissue as possible. The plan also aimed to retain the implant, depending on findings during surgery.
Vu said breast health assessments before cosmetic surgery are important, particularly for patients with a family history of breast cancer or other risk factors. Suspicious findings should be investigated, with biopsy performed when indicated.
On Sept. 23, Vu performed breast-conserving tumor excision at Nam Sai Gon International General Hospital.
The procedure used an ultrasonic surgical scalpel and intraoperative frozen section analysis to assess the surgical margins. According to Vu, examination of eight tissue specimens found no cancer cells at the sampled margins, suggesting the tumor had been removed with clear margins. Final pathology is needed to confirm the margin status and guide further treatment.
The patient subsequently underwent immunohistochemical testing for estrogen receptors (ER), progesterone receptors (PR), HER2 and Ki-67. The results will help determine the tumor's biological characteristics and guide postoperative treatment.
Depending on the final pathology, cancer stage and other clinical factors, further treatment may include radiotherapy, chemotherapy, endocrine therapy or HER2-targeted therapy.
The patient was advised to continue clinical follow-ups and breast imaging as recommended. Although the tumor was relatively small and imaging showed no suspicious lymph node enlargement, the available information does not establish her definitive cancer stage.
Breast health monitoring after augmentation
Vu said patients should continue age- and risk-appropriate breast cancer screening after breast augmentation.
For many augmentation procedures, he favors incisions beneath the breast fold rather than around the areola or nipple, saying this can reduce disruption to glandular tissue while allowing access for implant placement. However, the appropriate incision depends on each patient's anatomy, implant characteristics and clinical circumstances.
He also noted that scar tissue following surgery can sometimes complicate the interpretation of breast imaging.
![]() |
|
Dr. Ho Cao Vu emphasizes the importance of breast health monitoring following cosmetic breast surgery. Photo courtesy of the surgeon |
Patients should inform healthcare providers about their implants when undergoing mammography, ultrasound or other breast imaging. Implants do not eliminate the need for routine screening, and patients should seek medical assessment if they notice a new lump, changes in breast shape, persistent pain or other unusual symptoms.
Vu said his practice offers follow-up appointments six months and one, three, five and 10 years after augmentation, without additional consultation charges.
With more than 20 years of clinical experience, he said the program aims to monitor both surgical outcomes and breast health. Patients with abnormalities may be referred to specialized facilities, including HCMC Oncology Hospital and Cho Ray Hospital, for further evaluation and treatment.
Kim's case highlights how breast abnormalities can be detected during postoperative checkups and the importance of promptly investigating suspicious findings, including in patients who have undergone cosmetic breast surgery.